Advanced search
Publication Cover
Nanomedicine Volume 10, 2015 - Issue 1
Submit an article Journal homepage
159
Views
0
CrossRef citations to date
0
Altmetric
Preliminary Communication

Antibody-Engineered Nanoparticles Selectively Inhibit Mesenchymal Cells Isolated from Patients with Chronic Lung Allograft Dysfunction

Emanuela Cova1 Clinica di Malattie dell‘Apparato Respiratorio, IRCCS Fondazione Policlinico S Matteo, viale Golgi 19, 27100Pavia, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected]View further author information
,
Miriam Colombo2 Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Piazza della Scienza 2, 20126Milano, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected]View further author information
,
Simona Inghilleri1 Clinica di Malattie dell‘Apparato Respiratorio, IRCCS Fondazione Policlinico S Matteo, viale Golgi 19, 27100Pavia, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected]View further author information
,
Monica Morosini1 Clinica di Malattie dell‘Apparato Respiratorio, IRCCS Fondazione Policlinico S Matteo, viale Golgi 19, 27100Pavia, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected]View further author information
,
Simona Miserere1 Clinica di Malattie dell‘Apparato Respiratorio, IRCCS Fondazione Policlinico S Matteo, viale Golgi 19, 27100Pavia, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected]View further author information
,
Jesus Peñaranda-Avila2 Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Piazza della Scienza 2, 20126Milano, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected]View further author information
,
Benedetta Santini2 Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Piazza della Scienza 2, 20126Milano, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected]View further author information
,
Davide Piloni1 Clinica di Malattie dell‘Apparato Respiratorio, IRCCS Fondazione Policlinico S Matteo, viale Golgi 19, 27100Pavia, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected]View further author information
,
Sara Magni1 Clinica di Malattie dell‘Apparato Respiratorio, IRCCS Fondazione Policlinico S Matteo, viale Golgi 19, 27100Pavia, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected]View further author information
,
Furio Gramatica3 Laboratorio di Biofisica e Nanomedicina, Polo Tecnologico, Fondazione Don Gnocchi IRCCS-ONLUS, via Capacelatro 66, 20148Milan, ItalyView further author information
,
Davide Prosperi2 Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Piazza della Scienza 2, 20126Milano, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected];3 Laboratorio di Biofisica e Nanomedicina, Polo Tecnologico, Fondazione Don Gnocchi IRCCS-ONLUS, via Capacelatro 66, 20148Milan, ItalyView further author information
&
Federica Meloni1 Clinica di Malattie dell‘Apparato Respiratorio, IRCCS Fondazione Policlinico S Matteo, viale Golgi 19, 27100Pavia, Italy. Tel.: +39 0382 501 007 Fax: +39 0382 422 [email protected];4 Dipartimento di Medicina Molecolare, Unità di Pneumologia, Università di Pavia, viale Golgi 19, 27100Pavia, ItalyView further author information
 show all
Pages 9-23 | Published online: 21 Feb 2014

References

  • Giljohann DA , SeferosDS, DanielWL, MassichMD, PatelPC, MirkinCA. Gold nanoparticles for biology and medicine. Angew. Chem. Int. Ed.49 , 3280–3294 (2010).
  • Lu Y , ChenW. Sub-nanometre sized metal clusters: from synthetic challenges to the unique property discoveries. Chem. Soc. Rev.41 , 3594–3623 (2012).
  • Saha K , AgastiSS, KimC, LiX, RotelloVM. Gold nanoparticles in chemical and biological sensing. Chem. Rev.112 , 2739–2779 (2012).
  • Zijlstra P , PauloPMR, OrritM. Optical detection of single non-absorbing molecules using the surface plasmon resonance of a gold nanorod. Nat. Nanotech.7 , 379–782 (2012).
  • Sperling RA , Rivera Gil P, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chem. Soc. Rev.37 , 1896–1908 (2008).
  • Kim C , FavazzaC, WangLV. In vivo photoacoustic tomography of chemicals: high-resolution functional and molecular optical imaging at new depths. Chem. Rev.110 , 2756–2782 (2010).
  • Choi MR , Stanton-MaxeyKJ, StanleyJK et al. A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett. 7 , 3759–3765 (2007).
  • Hamad-Schifferli K , SchwartzJJ, SantosAT, ZhangS, JacobsonJM. Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna. Nature415 , 152–155 (2002).
  • Kim C , AgastiSS, ZhuZ, IsaacsL, RotelloVM. Recognition-mediated activation of therapeutic gold nanoparticles inside living cells. Nat. Chem.2 , 962–966 (2010).
  • Mukherjee P , BhattacharyaR, WangP et al. Antiangiogenic properties of gold nanoparticles. Clin. Cancer. Res. 1 , 3530–3534 (2005).
  • Kuriyama S , MitoroA, TsujinoueH et al. Particle-mediated gene transfer into murine livers using a newly developed gene gun. Gene Ther. 7 , 1132–1136 (2000).
  • Ghosh P , HanG, DeM, KimCK, RotelloVM. Gold nanoparticles in delivery applications. Adv. Drug Delivery Rev.60 , 1307–1315 (2008).
  • Cobley CM , ChenJ, Chul Cho E, Wang LV, Xia Y. Gold nanostructures: a class of multifunctional materials for biomedical applications. Chem. Soc. Rev.40 , 44–56 (2011).
  • Sandhu KK , McIntoshCM, SimardJM, SmithSW, RotelloVM. Gold nanoparticle-mediated transfection of mammalian cells. Bioconjugate Chem.13 , 3–6 (2002).
  • Yavuz MS , ChengY, ChenJ et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat. Mater. 8 , 935–939 (2009).
  • Rothrock AR , DonkersRL, SchoenfischMH. Synthesis of nitric oxide-releasing gold nanoparticles. J. Am. Chem. Soc.127 , 9362–9363 (2005).
  • Chen YS , HungYC, LiauI, HuangGS. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res. Lett.4 , 858–864 (2009).
  • Longmire M , ChoykePL, KobayashiH. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine3 , 703–717 (2008).
  • Connor EE , MwamukaJ, GoleA, MurphyCJ, WyattMD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small1 , 325–327 (2005).
  • Verleden GM , VosR, De Vleeschauwer SI et al. Obliterative bronchiolitis following lung transplantation: from old to new concepts? Transplant Int.22 , 771–779 (2009).
  • Finlen Copeland CA , SnyderLD, ZaasDW, TurbyfillWJ, DavisWA, PalmerSM. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. Am. J. Respir. Crit. Care Med.182 , 784–789 (2010).
  • Todd JL , PalmerSM. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest140 , 502–508 (2011).
  • Zheng L , WhitfordHM, OrsidaB et al. The dynamics and associations of airway neutrophilia post lung transplantation. Am. J. Transplant. 6 , 599–608 (2006).
  • Vanaudenaerde BM , VerledenSE, VosR et al. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. Am. J. Respir. Crit. Care Med. 183 , 977–986 (2011).
  • Palmer SM , BurchLH, TrindadeAJ et al. Innate immunity influences long-term outcomes after human lung transplant. Am. J. Respir. Crit. Care Med. 171 , 780–785 (2005).
  • Elssner A , VogelmeierC. The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation. Transplant. Infect. Dis.3 , 168–176 (2001).
  • Hardison MT , GalinFS, CalderonCE et al. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation. J. Immunol. 182 , 4423–4431 (2009).
  • Khatwa UA , KleibrinkBE, ShapiroSD, SubramaniamM. MMP-8 promotes polymorphonuclear cell migration through collagen barriers in obliterative bronchiolitis. J. Leukocyte Biol.87 , 69–77 (2010).
  • Andersson-Sjoland A , ThimanL, NihlbergK et al. Fibroblast phenotypes and their activity are changed in the wound healing process after lung transplantation. J. Heart. Lung. Transplant. 30 , 945–954 (2011).
  • Lama VN , SmithL, BadriL et al. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J. Clin. Invest. 117 , 989–996 (2007).
  • Brocker V , LangerF, FellousTG et al. Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants. Am. J. Respir. Crit. Care Med. 173 , 1276–1282 (2006).
  • Sato M , KeshavjeeS. Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling. Semin. Thorac. Cardiovasc. Surg.20 , 173–182 (2008).
  • Ramirez AM , NunleyDR, RojasM, RomanJ. Activation of tissue remodeling precedes obliterative bronchiolitis in lung transplant recipients. Biomarker Insights3 , 351–359 (2008).
  • Hayes D Jr. A review of bronchiolitis obliterans syndrome and therapeutic strategies. Cardiothorac. Surg.18 , 86–92 (2011).
  • Bianco R , GarofaloS, RosaR et al. Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs. Br. J. Cancer 98 , 923–930 (2008).
  • Azzola A , HavrykA, ChhajedP et al. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. Transplantation 77 , 275–280 (2004).
  • Nashan B . Review of the proliferation inhibitor everolimus. Expert. Opin. Invest. Drugs11 , 1845–1857 (2002).
  • Budde K , BeckerT, ArnsW et al. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet 377 , 837–847 (2011).
  • Otton J , HaywardCS, KeoghAM, GlanvilleAR, MacdonaldPS. Everolimus-associated pneumonitis in 3 heart transplant recipients. J. Heart Lung. Transplant.28 , 104–106 (2009).
  • Expósito V , de Prada JA, Gómez-Román JJ et al. Everolimus-related pulmonary toxicity in heart transplant recipients. J. Heart Lung Transplant.27 , 797–800 (2008).
  • Ponticelli C , SalvadoriM, ScolariMP et al. Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study. Transplantation 91 , e72–e73 (2011).
  • Iacono AT , JohnsonBA, GrgurichWF et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N. Engl. J. Med. 354 , 141–150 (2006).
  • Hayes D Jr, Zwischenberger JB, Mansour HM. Aerosolized tacrolimus: a case report in a lung transplant recipient. Transplant. Proc.42 , 3876–3879 (2010).
  • Dandel M , LehmkuhlHB, KnosallaC. Hetzer R. Impact of different long-term maintenance immunosuppressive therapy strategies on patients‘ outcome after heart transplantation. Transplant. Immunol.23 , 93–103 (2010).
  • Badri L , MurrayS, LiuLX et al. Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. Am. J. Respir. Crit. Care Med. 183 , 1062–1070 (2011).
  • Brust M , WalkerM, BethellD, SchiffrinDJ, WhymanRJ. Synthesis of thiol-derivatized gold nanoparticles in a two phase liquid-liquid system. Chem. Commun.801–802 (1994).
  • Colombo M , MazzucchelliS, MontenegroJM et al. Protein oriented ligation on nanoparticles exploiting O6-alkylguanine-DNA transferase (SNAP) genetically encoded fusion. Small 8 , 1492–1497 (2012).
  • Estenne M , MaurerJR, BoehlerA et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J. Heart Lung Transplant. 21 , 297–310 (2002).
  • Meloni F , CascinaA, MiserereS, PerottiC, VituloP, FiettaAM. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant. Proc.39 , 213–217 (2007).
  • No authors listed. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur. Respir. J.2 , 561–585 (1989).
  • Mazzucchelli S , ColomboM, De Palma C et al. Single-domain protein A-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells. ACS Nano4 , 5693–5702 (2010).
  • Cozens AL , YezziMJ, KunzelmannK et al. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 10 , 38–47 (1994).
  • Costa P , Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci.13 , 123–133 (2001).
  • Bellini A , MattoliS. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab. Invest.87 , 858–870 (2007).
  • Nombela-Arrieta C , RitzJ, SilbersteinLE. The elusive nature and function of mesenchymal stem cells. Nat. Rev. Mol. Cell Biol.12 , 126–131 (2011).
  • Andersson-Sjöland A , NihlbergK, ErikssonL, BjermerL, Westergren-ThorssonG. Fibrocytes and the tissue niche in lung repair. Respir. Res.12 , 76–83 (2011).
  • Zeisberg M , NeilsonEG. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest.119 , 1429–1437 (2009).
  • Walker N , BadriL, WettlauferS et al. Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. Am. J. Pathol. 178 , 2461–2469 (2011).
  • Zander DS , BazMA, MasseyJK. Patterns and significance of CD44 expression in lung allografts. J. Heart Lung Transplant.18 , 646–653 (1999).
  • Dancey J . mTOR signaling and drug development in cancer. Nat. Rev. Clin. Oncol.7 , 209–219 (2010).
  • Riise GC . On interleukin-8, neutrophil activation, and bronchiolitis obliterans syndrome in lung transplantation. Transplantation70 , 265–266 (2000).
  • Meloni F , VituloP, CascinaA et al. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 23 , 1053–1060 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.